查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
全球尿失禁設備市場按產品、失禁類型、患者類型、最終用戶和地區分類 - 預測至 2030 年
市場調查報告書
商品編碼
1681004

全球尿失禁設備市場按產品、失禁類型、患者類型、最終用戶和地區分類 - 預測至 2030 年

Urinary Incontinence Devices Market by Product (Urinary Catheters (Indwelling Catheters, Intermittent Catheters), Artificial Urinary Sphincters), Incontinence Type (Stress), Patient Type (Male, Female), End User (Hospitals) - Global Forecast to 2030
出版日期: | 出版商: MarketsandMarkets | 英文 291 Pages | 訂單完成後即時交付

價格

全球尿失禁設備市場規模預計將從 2024 年的 42.2 億美元成長到 2030 年的 79.7 億美元，預測期內的複合年成長率為 11.2%。

研究範圍
調查年份 2023-2030
基準年 2023
預測期 2023-2030
考慮單位 金額（十億美元）
部分 按產品、按失禁類型、按患者類型、按最終用戶、按地區
目標區域 北美、歐洲、亞太地區、拉丁美洲、中東和非洲

這是由於人們越來越重視個人衛生和家庭醫療保健解決方案的進步。此外，快速的都市化和不斷成長的可支配收入正在推動對尿失禁設備的需求。然而，使用導管等尿失禁裝置可能產生的副作用和併發症是市場發展的主要限制因素。此外，使用替代療法治療尿失禁是市場成長的一大挑戰。然而，在 2024-2030 年的預測期內，市場擴張的條件正在形成。

根據失禁類型，尿失禁設備市場分為應力性尿失禁、急迫性失禁、混合性失禁、充溢性失禁及功能性失禁。其中，壓力性尿失禁領域將在2023年佔據尿失禁設備市場最大的市場佔有率。推動應力性尿失禁領域成長的因素包括人口老化加劇和骨盆底功能障礙盛行率上升，尤其是在停經後婦女。應力性尿失禁的上升推動了對導尿管、陰道和尿道吊帶、人工尿道括約肌和電刺激裝置等尿失禁設備的需求。根據美國國家生物技術資訊中心（NCBI）的數據，應力性尿失禁（SUI）是最常見的疾病，佔病例的 37.5%。這種巨大的需求凸顯了對尿失禁設備日益成長的需求。

根據患者類型，尿失禁設備市場分為男性患者和女性患者。女性患者在尿失禁設備市場中佔據最大的市場佔有率。由於懷孕、分娩和閉經等因素，女性比男性更容易失禁。每次發生這些事件時，女性都可能遇到膀胱控制問題。懷孕可能是導致失禁和膀胱控制問題的短期原因。由於分娩會對骨盆底肌肉帶來壓力，有些女性在分娩後會出現失禁。在更年期期間，雌激素的下降會影響膀胱控制。然而，眾所周知，尿失禁的盛行率會隨著年齡的成長而增加，高達 75% 的 65 歲及以上女性報告出現尿失禁症狀，這進一步增加了該領域對尿失禁設備的市場需求。

本報告研究了全球尿失禁設備市場，並按產品、失禁類型、患者類型、最終用戶、區域趨勢和公司概況對市場進行了詳細分析。

目錄

第 1 章 簡介

第2章調查方法

第3章執行摘要

第 4 章重要考察

第5章 市場概況

  • 介紹
  • 市場動態
  • 定價分析
  • 價值鏈分析
  • 供應鏈分析
  • 生態系分析
  • 波特五力分析
  • 主要相關人員和採購標準
  • 監管狀態
  • 貿易分析
  • 專利分析
  • 2025-2026 年重要會議與活動
  • 影響客戶業務的趨勢/干擾
  • 技術分析
  • 投資金籌措場景
  • 人工智慧/生成式人工智慧對尿失禁設備市場的影響

第6章 尿失禁設備市場（依產品）

  • 介紹
  • 尿道導管
  • 陰道和尿道吊帶
  • 電刺激設備
  • 人工尿道括約肌
  • 其他

7. 尿失禁設備市場（依失禁類型）

  • 介紹
  • 應力性尿失禁
  • 急性尿失禁
  • 混合性失禁
  • 溢流性失禁
  • 功能性尿失禁

第 8 章 尿失禁治療設備市場（依患者類型）

  • 介紹
  • 女性患者
  • 男性患者

第9章尿失禁設備市場（依最終用戶分類）

  • 介紹
  • 醫院
  • 診所
  • 其他

第 10 章 尿失禁設備市場（按地區）

  • 介紹
  • 北美洲
    • 北美宏觀經濟展望
    • 美國
    • 加拿大
  • 歐洲
    • 歐洲宏觀經濟展望
    • 德國
    • 英國
    • 法國
    • 義大利
    • 西班牙
    • 其他
  • 亞太地區
    • 亞太宏觀經濟展望
    • 中國
    • 日本
    • 印度
    • 其他
  • 拉丁美洲
    • 拉丁美洲宏觀經濟展望
    • 巴西
    • 墨西哥
    • 其他
  • 中東和非洲
    • 改善醫療基礎設施以支持市場成長
    • 中東和非洲宏觀經濟展望

第11章 競爭格局

  • 介紹
  • 主要參與企業的策略/優勢
  • 2019 至 2023 年收益分析
  • 2023 年市場佔有率分析
  • 公司估值矩陣：主要參與企業，2023 年
  • 公司估值矩陣：Start-Ups/中小企業，2023 年
  • 估值及財務指標
  • 品牌/產品比較
  • 競爭場景

第12章 公司簡介

  • 主要參與企業
    • COLOPLAST CORP.
    • B. BRAUN SE
    • JOHNSON & JOHNSON SERVICES, INC.
    • CONVATEC INC.
    • BOSTON SCIENTIFIC CORPORATION
    • MEDTRONIC
    • TELEFLEX INCORPORATED
    • BECTON, DICKINSON AND COMPANY（BD）
    • CARDINAL HEALTH
    • HOLLISTER INCORPORATED
    • COOK GROUP
    • LABORIE
  • 其他公司
    • WELLSPECT HEALTHCARE
    • CALDERA MEDICAL
    • DYNAREX CORPORATION
    • ADVACARE PHARMA
    • MRK HEALTHCARE PVT. LTD.
    • ADVIN HEALTH CARE
    • CLINIMED LIMITED
    • STERIMED GROUP
    • KIMBERLY-CLARK CORPORATION（KCWW）
    • INCONTROL MEDICAL
    • ZEPHYR SURGICAL IMPLANTS
    • FLEXICARE（GROUP）LIMITED
    • STRYKER

第13章 附錄

Product Code: MD 9331

The global Urinary incontinence devices market is projected to reach USD 7.97 billion by 2030 from USD 4.22 billion in 2024, at a CAGR of 11.2% during the forecast period.

Scope of the Report
Years Considered for the Study2023-2030
Base Year2023
Forecast Period2023-2030
Units ConsideredValue (USD billion)
SegmentsProduct, Incontinence type, Patient type, End User, and Region
Regions coveredNorth America, Europe, APAC, LATAM, MEA

This is due to growing attention to personal hygiene and advancements in home healthcare solutions. Additionally, rapid urbanization and rising disposable income, consequently increasing the demand for the urinary incontinence devices. However, the potential side-effects & complications by using urinary incontinence devices such as catheters are the major restraint to the market. Additionally, the use of alternative treatment options to treat urinary icnotinence is major challenge for the market growth. But is creating a conducive environment for market expansion over the forecast period of 2024-2030.

"The stress incontinence segment of urinary incontinence devices market by incontinence type to hold largest position forecast period."

Based on the incontinence type, the urinary incontinence devices market is divided into stress incontinence, urge incontinence, mixed incontinence, overflow incontinence, and functional incontinence. Among these, in 2023 stress incontinence segment account for the largest market share of XX% in urinary incontinence devices market. Factors driving the growth of stress incontinence segment include rising aging population, which increases the prevalence of pelvic floor dysfunction, particularly among postmenopausal women. The growing prevalence of stress incontinence is driving demand for urinary incontinence devices, including urinary catheters, vaginal & urethral slings, artificial urinary sphincters, electrical stimulation devices are among the others. According to National Center for Biotechnology Information (NCBI), stress urinary incontinence (SUI) is the most reported type, accounting for 37.5% of cases. This significant prevalence highlights the growing demand for urinary incontinence devices.

"The female patients segment accounts for the largest market share in urinary incontinence devices market."

Based on patient type, the urinary incontinence devices market is segmented into male patients and female patients. The female patients segment accounts for the largest market share in urinary incontinence devices market. Women are more prone to incontinence than men, owing to factors such as pregnancy, childbirth, and menopause. During each of these events, women can face bladder control issues. Pregnancy can be a short-term cause of incontinence and bladder control issues. Some women experience incontinence after delivery because of the strain childbirth takes on the pelvic floor muscles. During menopause, the decreasing level of estrogen affects bladder control. However, the prevalence of incontinence is known to increase with age, with up to 75% of women above 65 years reporting an episode of incontinence such as urine leakage, further strengthens market demand for urinary incontinence devices among this segment.

"North America accounted for the second largest share of the urinary incontinence devices market by region."

The global urinary incontinence devices market is segmented into five major regions, namely, North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. Urinary incontinence devices market in North America is the second-largest regional market. This is due to the growing geriatric population along with rising prevalence of urinary incontinence as well as rapid advancement of healthcare infrastructure. The industry has long been established in the area, with high early-stage support and adoption by clinicians for research and emerging technologies. It is characterized by significant market penetration of urinary incontinence devices among key end users. However, the population of North America was approximately 375 million in 2023, with 66.8 million people aged 65 and above, a demographic that is particularly at risk of urinary incontinence. Such factors create a favorable environment for the growth of the urinary incontinence devices market in this region.

A breakdown of the primary participants referred to for this report is provided below:

  • By Company Type: Tier 1-40%, Tier 2-30%, and Tier 3- 30%
  • By Designation: C-level-27%, Director-level-18% and Others-55%
  • By Region: Europe-35%, North America-30%, Asia Pacific-22%, Latin America- 10%, and Middle east and Africa - 3%

Note 1: Note: Companies are classified into tiers based on their total revenue. As of 2023, Tier 1 = >USD 10.00 billion, Tier 2 = USD 1.00 billion to USD 10.00 billion, and Tier 3 = <USD 1.00 billion.

Note 2: C-level primaries include CEOs, CFOs, COOs, and VPs.

Note 3: Others include sales managers, marketing managers, business development managers, product managers, distributors, and suppliers.

The major players operating in the urinary incontinence devices market are Coloplast Corp (Denmark), B. Braun SE (Germany), Johnson & Johnson Services, Inc. (US), Convatec Inc. (UK), Boston Scientific Corporation (US), Hollister Incorporated (US), Becton, Dickinson and Company (BD) (US), Cook Group (US), Cardinal Health (US), Laborie (US), Medtronic (Ireland), and Teleflex Incorporated (US).

Research Coverage

This report studies the urinary incontinence devices market based on product, incontinence type, patient type, end user and region. The report also studies factors (such as drivers, restraints, opportunities, and challenges) affecting market growth and provides details of the competitive landscape for market leaders. Furthermore, the report analyzes micro markets with respect to their individual growth trends and forecasts the revenue of the market segments with respect to five major regions (and the respective countries in these regions).

Reasons to Buy the Report

The report will enable established firms as well as entrants/smaller firms to gauge the pulse of the market, which, in turn, would help them to garner a larger market share. Firms purchasing the report could use one or a combination of the below-mentioned strategies for strengthening their market presence.

This report provides insights on the following pointers:

  • Analysis of Key divers (Rising prevalence of urinary incontinence, Expanding geriatric population, Growing attention to personal hygiene, and Advancements in home healthcare solutions), restraints (Social stigma associate with incontinence care products, Environmental concerns related to disposal of urinary incontinence products, and Potential side-effects & complications), Challenge (Use of alternative treatment options), opportunity (Technological advancements in urinary incontinence devices and Rapid urbanization and rising disposable income)
  • Market Penetration: Comprehensive information on the product portfolios offered by the top players in the urinary incontinence devices market
  • Product Development/Innovation: Detailed insights on the upcoming trends, R&D activities, and product launches & product approvals in the urinary incontinence devices market
  • Market Development: Comprehensive information on lucrative emerging regions
  • Market Diversification: Exhaustive information about new products, growing geographies, and recent developments in the urinary incontinence devices market
  • Competitive Assessment: In-depth assessment of market segments, growth strategies, revenue analysis, and products of the leading market players

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 STUDY OBJECTIVES
  • 1.2 MARKET DEFINITION
  • 1.3 STUDY SCOPE
    • 1.3.1 MARKETS COVERED & REGIONS CONSIDERED
    • 1.3.2 INCLUSIONS & EXCLUSIONS
    • 1.3.3 YEARS CONSIDERED
    • 1.3.4 CURRENCY CONSIDERED
  • 1.4 STAKEHOLDERS

2 RESEARCH METHODOLOGY

  • 2.1 RESEARCH DATA
    • 2.1.1 SECONDARY DATA
      • 2.1.1.1 Key sources for secondary data
      • 2.1.1.2 Key data from secondary sources
    • 2.1.2 PRIMARY DATA
      • 2.1.2.1 Key primary sources
      • 2.1.2.2 Key data from primary sources
      • 2.1.2.3 Key industry insights
      • 2.1.2.4 Breakdown of primary interviews
  • 2.2 MARKET SIZE ESTIMATION
    • 2.2.1 BOTTOM-UP APPROACH
      • 2.2.1.1 Company revenue estimation approach
        • 2.2.1.1.1 Presentations of companies and primary interviews
        • 2.2.1.1.2 Primary interviews
        • 2.2.1.1.3 US-based approach
    • 2.2.2 TOP-DOWN APPROACH
  • 2.3 DATA TRIANGULATION
  • 2.4 MARKET SHARE ESTIMATION
  • 2.5 ASSUMPTIONS
    • 2.5.1 STUDY ASSUMPTIONS
    • 2.5.2 GROWTH RATE ASSUMPTIONS
  • 2.6 RESEARCH LIMITATIONS
    • 2.6.1 METHODOLOGY-RELATED LIMITATIONS
    • 2.6.2 SCOPE-RELATED LIMITATIONS
  • 2.7 RISK ASSESSMENT

3 EXECUTIVE SUMMARY

4 PREMIUM INSIGHTS

  • 4.1 URINARY INCONTINENCE DEVICES MARKET OVERVIEW
  • 4.2 ASIA PACIFIC: URINARY INCONTINENCE DEVICES MARKET, BY PRODUCT & COUNTRY (2023)
  • 4.3 GEOGRAPHIC GROWTH OPPORTUNITIES
  • 4.4 REGIONAL MIX: URINARY INCONTINENCE DEVICES MARKET, 2024 VS. 2030
  • 4.5 URINARY INCONTINENCE DEVICES MARKET: DEVELOPED VS. EMERGING MARKETS

5 MARKET OVERVIEW

  • 5.1 INTRODUCTION
  • 5.2 MARKET DYNAMICS
    • 5.2.1 DRIVERS
      • 5.2.1.1 Rising prevalence of urinary incontinence
      • 5.2.1.2 Expanding geriatric population
      • 5.2.1.3 Growing attention to personal hygiene
      • 5.2.1.4 Advancements in home healthcare solutions
    • 5.2.2 RESTRAINTS
      • 5.2.2.1 Social stigma associated with incontinence care products
      • 5.2.2.2 Environmental concerns related to disposal of urinary incontinence products
      • 5.2.2.3 Potential side-effects & complications
    • 5.2.3 OPPORTUNITIES
      • 5.2.3.1 Technological advancements in urinary incontinence devices
      • 5.2.3.2 Rapid urbanization and rising disposable income
    • 5.2.4 CHALLENGES
      • 5.2.4.1 Use of alternative treatment options
  • 5.3 PRICING ANALYSIS
    • 5.3.1 AVERAGE SELLING PRICE TREND, BY KEY PLAYER
    • 5.3.2 AVERAGE SELLING PRICE TREND, BY REGION
  • 5.4 VALUE CHAIN ANALYSIS
  • 5.5 SUPPLY CHAIN ANALYSIS
  • 5.6 ECOSYSTEM ANALYSIS
  • 5.7 PORTER'S FIVE FORCES ANALYSIS
    • 5.7.1 THREAT OF NEW ENTRANTS
    • 5.7.2 THREAT OF SUBSTITUTES
    • 5.7.3 BARGAINING POWER OF BUYERS
    • 5.7.4 BARGAINING POWER OF SUPPLIERS
    • 5.7.5 INTENSITY OF COMPETITIVE RIVALRY
  • 5.8 KEY STAKEHOLDERS & BUYING CRITERIA
    • 5.8.1 KEY STAKEHOLDERS IN BUYING PROCESS
    • 5.8.2 KEY BUYING CRITERIA
  • 5.9 REGULATORY LANDSCAPE
    • 5.9.1 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
    • 5.9.2 REGULATORY FRAMEWORK
      • 5.9.2.1 North America
        • 5.9.2.1.1 US
        • 5.9.2.1.2 Canada
      • 5.9.2.2 Europe
      • 5.9.2.3 Asia Pacific
        • 5.9.2.3.1 China
        • 5.9.2.3.2 Japan
        • 5.9.2.3.3 India
      • 5.9.2.4 Latin America
        • 5.9.2.4.1 Brazil
        • 5.9.2.4.2 Mexico
      • 5.9.2.5 Middle East
      • 5.9.2.6 Africa
  • 5.10 TRADE ANALYSIS
    • 5.10.1 IMPORT DATA FOR HS CODE 901839
    • 5.10.2 EXPORT DATA FOR HS CODE 901839
  • 5.11 PATENT ANALYSIS
    • 5.11.1 LIST OF MAJOR PATENTS
  • 5.12 KEY CONFERENCES & EVENTS, 2025-2026
  • 5.13 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS' BUSINESSES
  • 5.14 TECHNOLOGY ANALYSIS
    • 5.14.1 KEY TECHNOLOGIES
      • 5.14.1.1 Surgical & implantable devices
    • 5.14.2 COMPLEMENTARY TECHNOLOGIES
      • 5.14.2.1 Electrical stimulation devices
  • 5.15 INVESTMENT & FUNDING SCENARIO
  • 5.16 IMPACT OF AI/GEN AI ON URINARY INCONTINENCE DEVICES MARKET
    • 5.16.1 AI USE CASES

6 URINARY INCONTINENCE DEVICES MARKET, BY PRODUCT

  • 6.1 INTRODUCTION
  • 6.2 URINARY CATHETERS
    • 6.2.1 INTERMITTENT CATHETERS
      • 6.2.1.1 Reduced risk of infections to boost market
    • 6.2.2 INDWELLING CATHETERS
      • 6.2.2.1 Rising usage by critically ill patients to drive demand
    • 6.2.3 EXTERNAL CATHETERS
      • 6.2.3.1 Ease of use to boost market growth
  • 6.3 VAGINAL & URETHRAL SLINGS
    • 6.3.1 RISING PREVALENCE OF STRESS INCONTINENCE TO DRIVE GROWTH
  • 6.4 ELECTRICAL STIMULATION DEVICES
    • 6.4.1 GROWING PREFERENCE FOR ELECTRICAL STIMULATION DEVICES FOR TREATMENT OF OAB TO DRIVE GROWTH
  • 6.5 ARTIFICIAL URINARY SPHINCTERS
    • 6.5.1 REDUCED RISK OF INFECTIONS ASSOCIATED WITH ARTIFICIAL URINARY SPHINCTERS TO DRIVE ADOPTION
  • 6.6 OTHER URINARY INCONTINENCE DEVICES

7 URINARY INCONTINENCE DEVICES MARKET, BY INCONTINENCE TYPE

  • 7.1 INTRODUCTION
  • 7.2 STRESS INCONTINENCE
    • 7.2.1 GROWING PREVALENCE OF STRESS INCONTINENCE TO DRIVE MARKET GROWTH
  • 7.3 URGE INCONTINENCE
    • 7.3.1 CONTINUOUS INNOVATIONS TO SUSTAIN MARKET GROWTH
  • 7.4 MIXED INCONTINENCE
    • 7.4.1 GROWING AWARENESS AMONG BOTH PATIENTS AND HEALTHCARE PROVIDERS TO BOOST MARKET GROWTH
  • 7.5 OVERFLOW INCONTINENCE
    • 7.5.1 AGING POPULATION AND ASSOCIATED UROLOGICAL CONDITIONS TO DRIVE MARKET DEMAND
  • 7.6 FUNCTIONAL INCONTINENCE
    • 7.6.1 MOBILITY DISORDERS TO SUSTAIN MARKET GROWTH

8 URINARY INCONTINENCE DEVICES MARKET, BY PATIENT TYPE

  • 8.1 INTRODUCTION
  • 8.2 FEMALE PATIENTS
    • 8.2.1 HIGHER RATE OF URINARY INCONTINENCE IN FEMALES TO DRIVE MARKET
  • 8.3 MALE PATIENTS
    • 8.3.1 RISING PREVALENCE OF BPH TO PROPEL MARKET GROWTH

9 URINARY INCONTINENCE DEVICES MARKET, BY END USER

  • 9.1 INTRODUCTION
  • 9.2 HOSPITALS
    • 9.2.1 LARGE VOLUME OF SURGICAL PROCEDURES TO DRIVE GROWTH
  • 9.3 PHYSICIANS' OFFICES
    • 9.3.1 EXPERTISE OF PROFESSIONALS IN TREATMENT OF URINARY INCONTINENCE TO PROPEL GROWTH
  • 9.4 OTHER END USERS

10 URINARY INCONTINENCE DEVICES MARKET, BY REGION

  • 10.1 INTRODUCTION
  • 10.2 NORTH AMERICA
    • 10.2.1 MACROECONOMIC OUTLOOK FOR NORTH AMERICA
    • 10.2.2 US
      • 10.2.2.1 Favorable healthcare initiatives for prevention of UI to drive market
    • 10.2.3 CANADA
      • 10.2.3.1 Increasing geriatric population to drive market growth
  • 10.3 EUROPE
    • 10.3.1 MACROECONOMIC OUTLOOK FOR EUROPE
    • 10.3.2 GERMANY
      • 10.3.2.1 Rising healthcare expenditure to propel market
    • 10.3.3 UK
      • 10.3.3.1 Rising prevalence of chronic diseases to support market growth
    • 10.3.4 FRANCE
      • 10.3.4.1 Large target population to boost demand
    • 10.3.5 ITALY
      • 10.3.5.1 Rising geriatric population and subsequent rise in UI to drive market
    • 10.3.6 SPAIN
      • 10.3.6.1 Uptake of advanced technologies for UI treatment to support market growth
    • 10.3.7 REST OF EUROPE
  • 10.4 ASIA PACIFIC
    • 10.4.1 MACROECONOMIC OUTLOOK FOR ASIA PACIFIC
    • 10.4.2 CHINA
      • 10.4.2.1 Growing focus on preventive care due to large target patient pool to boost demand
    • 10.4.3 JAPAN
      • 10.4.3.1 Presence of established healthcare system and favorable reimbursements to drive market
    • 10.4.4 INDIA
      • 10.4.4.1 Rising cases of urinary incontinence and increasing healthcare investments to propel market
    • 10.4.5 REST OF ASIA PACIFIC
  • 10.5 LATIN AMERICA
    • 10.5.1 MACROECONOMIC OUTLOOK FOR LATIN AMERICA
    • 10.5.2 BRAZIL
      • 10.5.2.1 Favorable reimbursement scenario for medical device manufacturers to drive market
    • 10.5.3 MEXICO
      • 10.5.3.1 Rising demand for advanced UI products to drive market
    • 10.5.4 REST OF LATIN AMERICA
  • 10.6 MIDDLE EAST & AFRICA
    • 10.6.1 IMPROVEMENTS IN HEALTHCARE INFRASTRUCTURE TO SUPPORT MARKET GROWTH
    • 10.6.2 MACROECONOMIC OUTLOOK FOR MIDDLE EAST & AFRICA

11 COMPETITIVE LANDSCAPE

  • 11.1 INTRODUCTION
  • 11.2 KEY PLAYER STRATEGIES/RIGHT TO WIN
    • 11.2.1 OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS IN URINARY INCONTINENCE DEVICES MARKET
  • 11.3 REVENUE ANALYSIS, 2019-2023
  • 11.4 MARKET SHARE ANALYSIS, 2023
  • 11.5 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2023
    • 11.5.1 STARS
    • 11.5.2 EMERGING LEADERS
    • 11.5.3 PERVASIVE PLAYERS
    • 11.5.4 PARTICIPANTS
    • 11.5.5 COMPANY FOOTPRINT: KEY PLAYERS, 2023
      • 11.5.5.1 Company footprint
      • 11.5.5.2 Region footprint
      • 11.5.5.3 Product footprint
      • 11.5.5.4 Patient type footprint
      • 11.5.5.5 End-user footprint
  • 11.6 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2023
    • 11.6.1 PROGRESSIVE COMPANIES
    • 11.6.2 RESPONSIVE COMPANIES
    • 11.6.3 DYNAMIC COMPANIES
    • 11.6.4 STARTING BLOCKS
    • 11.6.5 COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2023
      • 11.6.5.1 Detailed list of key startup/SME players
      • 11.6.5.2 Competitive benchmarking of key emerging players/startups
  • 11.7 COMPANY VALUATION & FINANCIAL METRICS
  • 11.8 BRAND/PRODUCT COMPARISON
  • 11.9 COMPETITIVE SCENARIO
    • 11.9.1 PRODUCT LAUNCHES & APPROVALS
    • 11.9.2 DEALS
    • 11.9.3 EXPANSIONS
    • 11.9.4 OTHER DEVELOPMENTS

12 COMPANY PROFILES

  • 12.1 KEY PLAYERS
    • 12.1.1 COLOPLAST CORP.
      • 12.1.1.1 Business overview
      • 12.1.1.2 Products offered
      • 12.1.1.3 Recent developments
        • 12.1.1.3.1 Product launches
        • 12.1.1.3.2 Expansions
      • 12.1.1.4 MnM view
        • 12.1.1.4.1 Key strengths
        • 12.1.1.4.2 Strategic choices
        • 12.1.1.4.3 Weaknesses & competitive threats
    • 12.1.2 B. BRAUN SE
      • 12.1.2.1 Business overview
      • 12.1.2.2 Products offered
      • 12.1.2.3 MnM view
        • 12.1.2.3.1 Key strengths
        • 12.1.2.3.2 Strategic choices
        • 12.1.2.3.3 Weaknesses & competitive threats
    • 12.1.3 JOHNSON & JOHNSON SERVICES, INC.
      • 12.1.3.1 Business overview
      • 12.1.3.2 Products offered
      • 12.1.3.3 MnM view
        • 12.1.3.3.1 Key strengths
        • 12.1.3.3.2 Strategic choices
        • 12.1.3.3.3 Weaknesses & competitive threats
    • 12.1.4 CONVATEC INC.
      • 12.1.4.1 Business overview
      • 12.1.4.2 Products offered
      • 12.1.4.3 Recent developments
        • 12.1.4.3.1 Product launches
        • 12.1.4.3.2 Deals
      • 12.1.4.4 MnM view
        • 12.1.4.4.1 Key strengths
        • 12.1.4.4.2 Strategic choices
        • 12.1.4.4.3 Weaknesses & competitive threats
    • 12.1.5 BOSTON SCIENTIFIC CORPORATION
      • 12.1.5.1 Business overview
      • 12.1.5.2 Products offered
      • 12.1.5.3 Recent developments
        • 12.1.5.3.1 Deals
      • 12.1.5.4 MnM view
        • 12.1.5.4.1 Key strengths
        • 12.1.5.4.2 Strategic choices
        • 12.1.5.4.3 Weaknesses & competitive threats
    • 12.1.6 MEDTRONIC
      • 12.1.6.1 Business overview
      • 12.1.6.2 Products offered
      • 12.1.6.3 Recent developments
        • 12.1.6.3.1 Product approvals
    • 12.1.7 TELEFLEX INCORPORATED
      • 12.1.7.1 Business overview
      • 12.1.7.2 Products offered
    • 12.1.8 BECTON, DICKINSON AND COMPANY (BD)
      • 12.1.8.1 Business overview
      • 12.1.8.2 Products offered
    • 12.1.9 CARDINAL HEALTH
      • 12.1.9.1 Business overview
      • 12.1.9.2 Products offered
    • 12.1.10 HOLLISTER INCORPORATED
      • 12.1.10.1 Business overview
      • 12.1.10.2 Products offered
      • 12.1.10.3 Recent developments
        • 12.1.10.3.1 Product launches
    • 12.1.11 COOK GROUP
      • 12.1.11.1 Business overview
      • 12.1.11.2 Products offered
    • 12.1.12 LABORIE
      • 12.1.12.1 Business overview
      • 12.1.12.2 Products offered
      • 12.1.12.3 Recent developments
        • 12.1.12.3.1 Other developments
  • 12.2 OTHER PLAYERS
    • 12.2.1 WELLSPECT HEALTHCARE
    • 12.2.2 CALDERA MEDICAL
    • 12.2.3 DYNAREX CORPORATION
    • 12.2.4 ADVACARE PHARMA
    • 12.2.5 MRK HEALTHCARE PVT. LTD.
    • 12.2.6 ADVIN HEALTH CARE
    • 12.2.7 CLINIMED LIMITED
    • 12.2.8 STERIMED GROUP
    • 12.2.9 KIMBERLY-CLARK CORPORATION (KCWW)
    • 12.2.10 INCONTROL MEDICAL
    • 12.2.11 ZEPHYR SURGICAL IMPLANTS
    • 12.2.12 FLEXICARE (GROUP) LIMITED
    • 12.2.13 STRYKER

13 APPENDIX

  • 13.1 DISCUSSION GUIDE
  • 13.2 KNOWLEDGESTORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
  • 13.3 CUSTOMIZATION OPTIONS
  • 13.4 RELATED REPORTS
  • 13.5 AUTHOR DETAILS

List of Tables

  • TABLE 1 URINARY INCONTINENCE DEVICES MARKET: KEY DATA FROM PRIMARY SOURCES
  • TABLE 2 URINARY INCONTINENCE DEVICES MARKET: STUDY ASSUMPTIONS
  • TABLE 3 URINARY INCONTINENCE DEVICES MARKET: RISK ASSESSMENT
  • TABLE 4 PREVALENCE OF URINARY INCONTINENCE AMONG OLDER WOMEN, BY REGION
  • TABLE 5 AVERAGE SELLING PRICE TREND OF URINARY INCONTINENCE DEVICES, BY KEY PLAYER, 2022-2024
  • TABLE 6 AVERAGE SELLING PRICE TREND OF URINARY INCONTINENCE DEVICES, BY REGION, 2021-2023
  • TABLE 7 URINARY INCONTINENCE DEVICES MARKET: ROLE IN ECOSYSTEM
  • TABLE 8 URINARY INCONTINENCE DEVICES MARKET: PORTER'S FIVE FORCES
  • TABLE 9 INFLUENCE OF KEY STAKEHOLDERS ON BUYING PROCESS (%)
  • TABLE 10 KEY BUYING CRITERIA FOR MAJOR END USERS
  • TABLE 11 NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 12 EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 13 ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 14 LATIN AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 15 REST OF THE WORLD: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 16 US FDA: MEDICAL DEVICE CLASSIFICATION
  • TABLE 17 US: MEDICAL DEVICE REGULATORY APPROVAL PROCESS
  • TABLE 18 IMPORT DATA FOR HS CODE 901839, BY COUNTRY, 2020-2024 (USD THOUSAND)
  • TABLE 19 EXPORT DATA FOR HS CODE 901839, BY COUNTRY, 2020-2024 (USD THOUSAND)
  • TABLE 20 URINARY INCONTINENCE DEVICES MARKET: LIST OF MAJOR PATENTS
  • TABLE 21 URINARY INCONTINENCE DEVICES MARKET: KEY CONFERENCES & EVENTS, JANUARY 2025-DECEMBER 2026
  • TABLE 22 URINARY INCONTINENCE DEVICES MARKET, BY PRODUCT, 2022-2030 (USD MILLION)
  • TABLE 23 URINARY INCONTINENCE DEVICES MARKET FOR URINARY CATHETERS, BY REGION, 2022-2030 (USD MILLION)
  • TABLE 24 NORTH AMERICA: URINARY INCONTINENCE DEVICES MARKET FOR URINARY CATHETERS, BY COUNTRY, 2022-2030 (USD MILLION)
  • TABLE 25 EUROPE: URINARY INCONTINENCE DEVICES MARKET FOR URINARY CATHETERS, BY COUNTRY, 2022-2030 (USD MILLION)
  • TABLE 26 ASIA PACIFIC: URINARY INCONTINENCE DEVICES MARKET FOR URINARY CATHETERS, BY COUNTRY, 2022-2030 (USD MILLION)
  • TABLE 27 LATIN AMERICA: URINARY INCONTINENCE DEVICES MARKET FOR URINARY CATHETERS, BY COUNTRY, 2022-2030 (USD MILLION)
  • TABLE 28 URINARY INCONTINENCE DEVICES MARKET FOR URINARY CATHETERS, BY TYPE, 2022-2030 (USD MILLION)
  • TABLE 29 URINARY INCONTINENCE DEVICES MARKET FOR INTERMITTENT CATHETERS, BY REGION, 2022-2030 (USD MILLION)
  • TABLE 30 NORTH AMERICA: URINARY INCONTINENCE DEVICES MARKET FOR INTERMITTENT CATHETERS, BY COUNTRY, 2022-2030 (USD MILLION)
  • TABLE 31 EUROPE: URINARY INCONTINENCE DEVICES MARKET FOR INTERMITTENT CATHETERS, BY COUNTRY, 2022-2030 (USD MILLION)
  • TABLE 32 ASIA PACIFIC: URINARY INCONTINENCE DEVICES MARKET FOR INTERMITTENT CATHETERS, BY COUNTRY, 2022-2030 (USD MILLION)
  • TABLE 33 LATIN AMERICA: URINARY INCONTINENCE DEVICES MARKET FOR INTERMITTENT CATHETERS, BY COUNTRY, 2022-2030 (USD MILLION)
  • TABLE 34 URINARY INCONTINENCE DEVICES MARKET FOR INDWELLING CATHETERS, BY REGION, 2022-2030 (USD MILLION)
  • TABLE 35 NORTH AMERICA: URINARY INCONTINENCE DEVICES MARKET FOR INDWELLING CATHETERS, BY COUNTRY, 2022-2030 (USD MILLION)
  • TABLE 36 EUROPE: URINARY INCONTINENCE DEVICES MARKET FOR INDWELLING CATHETERS, BY COUNTRY, 2022-2030 (USD MILLION)
  • TABLE 37 ASIA PACIFIC: URINARY INCONTINENCE DEVICES MARKET FOR INDWELLING CATHETERS, BY COUNTRY, 2022-2030 (USD MILLION)
  • TABLE 38 LATIN AMERICA: URINARY INCONTINENCE DEVICES MARKET FOR INDWELLING CATHETERS, BY COUNTRY, 2022-2030 (USD MILLION)
  • TABLE 39 URINARY INCONTINENCE DEVICES MARKET FOR EXTERNAL CATHETERS, BY REGION, 2022-2030 (USD MILLION)
  • TABLE 40 NORTH AMERICA: URINARY INCONTINENCE DEVICES MARKET FOR EXTERNAL CATHETERS, BY COUNTRY, 2022-2030 (USD MILLION)
  • TABLE 41 EUROPE: URINARY INCONTINENCE DEVICES MARKET FOR EXTERNAL CATHETERS, BY COUNTRY, 2022-2030 (USD MILLION)
  • TABLE 42 ASIA PACIFIC: URINARY INCONTINENCE DEVICES MARKET FOR EXTERNAL CATHETERS, BY COUNTRY, 2022-2030 (USD MILLION)
  • TABLE 43 LATIN AMERICA: URINARY INCONTINENCE DEVICES MARKET FOR EXTERNAL CATHETERS, BY COUNTRY, 2022-2030 (USD MILLION)
  • TABLE 44 URINARY INCONTINENCE DEVICES MARKET FOR VAGINAL & URETHRAL SLINGS, BY REGION, 2022-2030 (USD MILLION)
  • TABLE 45 NORTH AMERICA: URINARY INCONTINENCE DEVICES MARKET FOR VAGINAL & URETHRAL SLINGS, BY COUNTRY, 2022-2030 (USD MILLION)
  • TABLE 46 EUROPE: URINARY INCONTINENCE DEVICES MARKET FOR VAGINAL & URETHRAL SLINGS, BY COUNTRY, 2022-2030 (USD MILLION)
  • TABLE 47 ASIA PACIFIC: URINARY INCONTINENCE DEVICES MARKET FOR VAGINAL & URETHRAL SLINGS, BY COUNTRY, 2022-2030 (USD MILLION)
  • TABLE 48 LATIN AMERICA: URINARY INCONTINENCE DEVICES MARKET FOR VAGINAL & URETHRAL SLINGS, BY COUNTRY, 2022-2030 (USD MILLION)
  • TABLE 49 URINARY INCONTINENCE DEVICES MARKET FOR ELECTRICAL STIMULATION DEVICES, BY REGION, 2022-2030 (USD MILLION)
  • TABLE 50 NORTH AMERICA: URINARY INCONTINENCE DEVICES MARKET FOR ELECTRICAL STIMULATION DEVICES, BY COUNTRY, 2022-2030 (USD MILLION)
  • TABLE 51 EUROPE: URINARY INCONTINENCE DEVICES MARKET FOR ELECTRICAL STIMULATION DEVICES, BY COUNTRY, 2022-2030 (USD MILLION)
  • TABLE 52 ASIA PACIFIC: URINARY INCONTINENCE DEVICES MARKET FOR ELECTRICAL STIMULATION DEVICES, BY COUNTRY, 2022-2030 (USD MILLION)
  • TABLE 53 LATIN AMERICA: URINARY INCONTINENCE DEVICES MARKET FOR ELECTRICAL STIMULATION DEVICES, BY COUNTRY, 2022-2030 (USD MILLION)
  • TABLE 54 URINARY INCONTINENCE DEVICES MARKET FOR ARTIFICIAL URINARY SPHINCTERS, BY REGION, 2022-2030 (USD MILLION)
  • TABLE 55 NORTH AMERICA: URINARY INCONTINENCE DEVICES MARKET FOR ARTIFICIAL URINARY SPHINCTERS, BY COUNTRY, 2022-2030 (USD MILLION)
  • TABLE 56 EUROPE: URINARY INCONTINENCE DEVICES MARKET FOR ARTIFICIAL URINARY SPHINCTERS, BY COUNTRY, 2022-2030 (USD MILLION)
  • TABLE 57 ASIA PACIFIC: URINARY INCONTINENCE DEVICES MARKET FOR ARTIFICIAL URINARY SPHINCTERS, BY COUNTRY, 2022-2030 (USD MILLION)
  • TABLE 58 LATIN AMERICA: URINARY INCONTINENCE DEVICES MARKET FOR ARTIFICIAL URINARY SPHINCTERS, BY COUNTRY, 2022-2030 (USD MILLION)
  • TABLE 59 OTHER URINARY INCONTINENCE DEVICES MARKET, BY REGION, 2022-2030 (USD MILLION)
  • TABLE 60 NORTH AMERICA: OTHER URINARY INCONTINENCE DEVICES MARKET, BY COUNTRY, 2022-2030 (USD MILLION)
  • TABLE 61 EUROPE: OTHER URINARY INCONTINENCE DEVICES MARKET, BY COUNTRY, 2022-2030 (USD MILLION)
  • TABLE 62 ASIA PACIFIC: OTHER URINARY INCONTINENCE DEVICES MARKET, BY COUNTRY, 2022-2030 (USD MILLION)
  • TABLE 63 LATIN AMERICA: OTHER URINARY INCONTINENCE DEVICES MARKET, BY COUNTRY, 2022-2030 (USD MILLION)
  • TABLE 64 URINARY INCONTINENCE DEVICES MARKET, BY INCONTINENCE TYPE, 2022-2030 (USD MILLION)
  • TABLE 65 KEY PRODUCTS FOR TREATMENT OF STRESS INCONTINENCE
  • TABLE 66 URINARY INCONTINENCE DEVICES MARKET FOR STRESS INCONTINENCE, BY REGION, 2022-2030 (USD MILLION)
  • TABLE 67 NORTH AMERICA: URINARY INCONTINENCE DEVICES MARKET FOR STRESS INCONTINENCE, BY COUNTRY, 2022-2030 (USD MILLION)
  • TABLE 68 EUROPE: URINARY INCONTINENCE DEVICES MARKET FOR STRESS INCONTINENCE, BY COUNTRY, 2022-2030 (USD MILLION)
  • TABLE 69 ASIA PACIFIC: URINARY INCONTINENCE DEVICES MARKET FOR STRESS INCONTINENCE, BY COUNTRY, 2022-2030 (USD MILLION)
  • TABLE 70 LATIN AMERICA: URINARY INCONTINENCE DEVICES MARKET FOR STRESS INCONTINENCE, BY COUNTRY, 2022-2030 (USD MILLION)
  • TABLE 71 URINARY INCONTINENCE DEVICES MARKET FOR URGE INCONTINENCE, BY REGION, 2022-2030 (USD MILLION)
  • TABLE 72 NORTH AMERICA: URINARY INCONTINENCE DEVICES MARKET FOR URGE INCONTINENCE, BY COUNTRY, 2022-2030 (USD MILLION)
  • TABLE 73 EUROPE: URINARY INCONTINENCE DEVICES MARKET FOR URGE INCONTINENCE, BY COUNTRY, 2022-2030 (USD MILLION)
  • TABLE 74 ASIA PACIFIC: URINARY INCONTINENCE DEVICES MARKET FOR URGE INCONTINENCE, BY COUNTRY, 2022-2030 (USD MILLION)
  • TABLE 75 LATIN AMERICA: URINARY INCONTINENCE DEVICES MARKET FOR URGE INCONTINENCE, BY COUNTRY, 2022-2030 (USD MILLION)
  • TABLE 76 URINARY INCONTINENCE DEVICES MARKET FOR MIXED INCONTINENCE, BY REGION, 2022-2030 (USD MILLION)
  • TABLE 77 NORTH AMERICA: URINARY INCONTINENCE DEVICES MARKET FOR MIXED INCONTINENCE, BY COUNTRY, 2022-2030 (USD MILLION)
  • TABLE 78 EUROPE: URINARY INCONTINENCE DEVICES MARKET FOR MIXED INCONTINENCE, BY COUNTRY, 2022-2030 (USD MILLION)
  • TABLE 79 ASIA PACIFIC: URINARY INCONTINENCE DEVICES MARKET FOR MIXED INCONTINENCE, BY COUNTRY, 2022-2030 (USD MILLION)
  • TABLE 80 LATIN AMERICA: URINARY INCONTINENCE DEVICES MARKET FOR MIXED INCONTINENCE, BY COUNTRY, 2022-2030 (USD MILLION)
  • TABLE 81 URINARY INCONTINENCE DEVICES MARKET FOR OVERFLOW INCONTINENCE, BY REGION, 2022-2030 (USD MILLION)
  • TABLE 82 NORTH AMERICA: URINARY INCONTINENCE DEVICES MARKET FOR OVERFLOW INCONTINENCE, BY COUNTRY, 2022-2030 (USD MILLION)
  • TABLE 83 EUROPE: URINARY INCONTINENCE DEVICES MARKET FOR OVERFLOW INCONTINENCE, BY COUNTRY, 2022-2030 (USD MILLION)
  • TABLE 84 ASIA PACIFIC: URINARY INCONTINENCE DEVICES MARKET FOR OVERFLOW INCONTINENCE, BY COUNTRY, 2022-2030 (USD MILLION)
  • TABLE 85 LATIN AMERICA: URINARY INCONTINENCE DEVICES MARKET FOR OVERFLOW INCONTINENCE, BY COUNTRY, 2022-2030 (USD MILLION)
  • TABLE 86 URINARY INCONTINENCE DEVICES MARKET FOR FUNCTIONAL INCONTINENCE, BY REGION, 2022-2030 (USD MILLION)
  • TABLE 87 NORTH AMERICA: URINARY INCONTINENCE DEVICES MARKET FOR FUNCTIONAL INCONTINENCE, BY COUNTRY, 2022-2030 (USD MILLION)
  • TABLE 88 EUROPE: URINARY INCONTINENCE DEVICES MARKET FOR FUNCTIONAL INCONTINENCE, BY COUNTRY, 2022-2030 (USD MILLION)
  • TABLE 89 ASIA PACIFIC: URINARY INCONTINENCE DEVICES MARKET FOR FUNCTIONAL INCONTINENCE, BY COUNTRY, 2022-2030 (USD MILLION)
  • TABLE 90 LATIN AMERICA: URINARY INCONTINENCE DEVICES MARKET FOR FUNCTIONAL INCONTINENCE, BY COUNTRY, 2022-2030 (USD MILLION)
  • TABLE 91 URINARY INCONTINENCE DEVICES MARKET, BY PATIENT TYPE, 2022-2030 (USD MILLION)
  • TABLE 92 URINARY INCONTINENCE DEVICES MARKET FOR FEMALE PATIENTS, BY REGION, 2022-2030 (USD MILLION)
  • TABLE 93 NORTH AMERICA: URINARY INCONTINENCE DEVICES MARKET FOR FEMALE PATIENTS, BY COUNTRY, 2022-2030 (USD MILLION)
  • TABLE 94 EUROPE: URINARY INCONTINENCE DEVICES MARKET FOR FEMALE PATIENTS, BY COUNTRY, 2022-2030 (USD MILLION)
  • TABLE 95 ASIA PACIFIC: URINARY INCONTINENCE DEVICES MARKET FOR FEMALE PATIENTS, BY COUNTRY, 2022-2030 (USD MILLION)
  • TABLE 96 LATIN AMERICA: URINARY INCONTINENCE DEVICES MARKET FOR FEMALE PATIENTS, BY COUNTRY, 2022-2030 (USD MILLION)
  • TABLE 97 URINARY INCONTINENCE DEVICES MARKET FOR MALE PATIENTS, BY REGION, 2022-2030 (USD MILLION)
  • TABLE 98 NORTH AMERICA: URINARY INCONTINENCE DEVICES MARKET FOR MALE PATIENTS, BY COUNTRY, 2022-2030 (USD MILLION)
  • TABLE 99 EUROPE: URINARY INCONTINENCE DEVICES MARKET FOR MALE PATIENTS, BY COUNTRY, 2022-2030 (USD MILLION)
  • TABLE 100 ASIA PACIFIC: URINARY INCONTINENCE DEVICES MARKET FOR MALE PATIENTS, BY COUNTRY, 2022-2030 (USD MILLION)
  • TABLE 101 LATIN AMERICA: URINARY INCONTINENCE DEVICES MARKET FOR MALE PATIENTS, BY COUNTRY, 2022-2030 (USD MILLION)
  • TABLE 102 URINARY INCONTINENCE DEVICES MARKET, BY END USER, 2022-2030 (USD MILLION)
  • TABLE 103 URINARY INCONTINENCE DEVICES MARKET FOR HOSPITALS, BY REGION, 2022-2030 (USD MILLION)
  • TABLE 104 NORTH AMERICA: URINARY INCONTINENCE DEVICES MARKET FOR HOSPITALS, BY COUNTRY, 2022-2030 (USD MILLION)
  • TABLE 105 EUROPE: URINARY INCONTINENCE DEVICES MARKET FOR HOSPITALS, BY COUNTRY, 2022-2030 (USD MILLION)
  • TABLE 106 ASIA PACIFIC: URINARY INCONTINENCE DEVICES MARKET FOR HOSPITALS, BY COUNTRY, 2022-2030 (USD MILLION)
  • TABLE 107 LATIN AMERICA: URINARY INCONTINENCE DEVICES MARKET FOR HOSPITALS, BY COUNTRY, 2022-2030 (USD MILLION)
  • TABLE 108 URINARY INCONTINENCE DEVICES MARKET FOR PHYSICIANS' OFFICES, BY REGION, 2022-2030 (USD MILLION)
  • TABLE 109 NORTH AMERICA: URINARY INCONTINENCE DEVICES MARKET FOR PHYSICIANS' OFFICES, BY COUNTRY, 2022-2030 (USD MILLION)
  • TABLE 110 EUROPE: URINARY INCONTINENCE DEVICES MARKET FOR PHYSICIANS' OFFICES, BY COUNTRY, 2022-2030 (USD MILLION)
  • TABLE 111 ASIA PACIFIC: URINARY INCONTINENCE DEVICES MARKET FOR PHYSICIANS' OFFICES, BY COUNTRY, 2022-2030 (USD MILLION)
  • TABLE 112 LATIN AMERICA: URINARY INCONTINENCE DEVICES MARKET FOR PHYSICIANS' OFFICES, BY COUNTRY, 2022-2030 (USD MILLION)
  • TABLE 113 URINARY INCONTINENCE DEVICES MARKET FOR OTHER END USERS, BY REGION, 2022-2030 (USD MILLION)
  • TABLE 114 NORTH AMERICA: URINARY INCONTINENCE DEVICES MARKET FOR OTHER END USERS, BY COUNTRY, 2022-2030 (USD MILLION)
  • TABLE 115 EUROPE: URINARY INCONTINENCE DEVICES MARKET FOR OTHER END USERS, BY COUNTRY, 2022-2030 (USD MILLION)
  • TABLE 116 ASIA PACIFIC: URINARY INCONTINENCE DEVICES MARKET FOR OTHER END USERS, BY COUNTRY, 2022-2030 (USD MILLION)
  • TABLE 117 LATIN AMERICA: URINARY INCONTINENCE DEVICES MARKET FOR OTHER END USERS, BY COUNTRY, 2022-2030 (USD MILLION)
  • TABLE 118 URINARY INCONTINENCE DEVICES MARKET, BY REGION, 2022-2030 (USD MILLION)
  • TABLE 119 NORTH AMERICA: MACROECONOMIC INDICATORS
  • TABLE 120 NORTH AMERICA: URINARY INCONTINENCE DEVICES MARKET, BY PRODUCT, 2022-2030 (USD MILLION)
  • TABLE 121 NORTH AMERICA: URINARY INCONTINENCE DEVICES MARKET FOR URINARY CATHETERS, BY TYPE, 2022-2030 (USD MILLION)
  • TABLE 122 NORTH AMERICA: URINARY INCONTINENCE DEVICES MARKET, BY INCONTINENCE TYPE, 2022-2030 (USD MILLION)
  • TABLE 123 NORTH AMERICA: URINARY INCONTINENCE DEVICES MARKET, BY PATIENT TYPE, 2022-2030 (USD MILLION)
  • TABLE 124 NORTH AMERICA: URINARY INCONTINENCE DEVICES MARKET, BY END USER, 2022-2030 (USD MILLION)
  • TABLE 125 NORTH AMERICA: URINARY INCONTINENCE DEVICES MARKET, BY COUNTRY, 2022-2030 (USD MILLION)
  • TABLE 126 US: NUMBER OF INDWELLING/FOLEY CATHETERS SOLD IN US (MILLION)
  • TABLE 127 US: URINARY INCONTINENCE DEVICES MARKET, BY PRODUCT, 2022-2030 (USD MILLION)
  • TABLE 128 US: URINARY INCONTINENCE DEVICES MARKET FOR URINARY CATHETERS, BY TYPE, 2022-2030 (USD MILLION)
  • TABLE 129 US: URINARY INCONTINENCE DEVICES MARKET, BY INCONTINENCE TYPE, 2022-2030 (USD MILLION)
  • TABLE 130 US: URINARY INCONTINENCE DEVICES MARKET, BY PATIENT TYPE, 2022-2030 (USD MILLION)
  • TABLE 131 US: URINARY INCONTINENCE DEVICES MARKET, BY END USER, 2022-2030 (USD MILLION)
  • TABLE 132 CANADA: URINARY INCONTINENCE DEVICES MARKET, BY PRODUCT, 2022-2030 (USD MILLION)
  • TABLE 133 CANADA: URINARY INCONTINENCE DEVICES MARKET FOR URINARY CATHETERS, BY TYPE, 2022-2030 (USD MILLION)
  • TABLE 134 CANADA: URINARY INCONTINENCE DEVICES MARKET, BY INCONTINENCE TYPE, 2022-2030 (USD MILLION)
  • TABLE 135 CANADA: URINARY INCONTINENCE DEVICES MARKET, BY PATIENT TYPE, 2022-2030 (USD MILLION)
  • TABLE 136 CANADA: URINARY INCONTINENCE DEVICES MARKET, BY END USER, 2022-2030 (USD MILLION)
  • TABLE 137 EUROPE: MACROECONOMIC INDICATORS
  • TABLE 138 EUROPE: URINARY INCONTINENCE DEVICES MARKET, BY PRODUCT, 2022-2030 (USD MILLION)
  • TABLE 139 EUROPE: URINARY INCONTINENCE DEVICES MARKET FOR URINARY CATHETERS, BY TYPE, 2022-2030 (USD MILLION)
  • TABLE 140 EUROPE: URINARY INCONTINENCE DEVICES MARKET, BY INCONTINENCE TYPE, 2022-2030 (USD MILLION)
  • TABLE 141 EUROPE: URINARY INCONTINENCE DEVICES MARKET, BY PATIENT TYPE, 2022-2030 (USD MILLION)
  • TABLE 142 EUROPE: URINARY INCONTINENCE DEVICES MARKET, BY END USER, 2022-2030 (USD MILLION)
  • TABLE 143 EUROPE: URINARY INCONTINENCE DEVICES MARKET, BY COUNTRY, 2022-2030 (USD MILLION)
  • TABLE 144 GERMANY: URINARY INCONTINENCE DEVICES MARKET, BY PRODUCT, 2022-2030 (USD MILLION)
  • TABLE 145 GERMANY: URINARY INCONTINENCE DEVICES MARKET FOR URINARY CATHETERS, BY TYPE, 2022-2030 (USD MILLION)
  • TABLE 146 GERMANY: URINARY INCONTINENCE DEVICES MARKET, BY INCONTINENCE TYPE, 2022-2030 (USD MILLION)
  • TABLE 147 GERMANY: URINARY INCONTINENCE DEVICES MARKET, BY PATIENT TYPE, 2022-2030 (USD MILLION)
  • TABLE 148 GERMANY: URINARY INCONTINENCE DEVICES MARKET, BY END USER, 2022-2030 (USD MILLION)
  • TABLE 149 UK: URINARY INCONTINENCE DEVICES MARKET, BY PRODUCT, 2022-2030 (USD MILLION)
  • TABLE 150 UK: URINARY INCONTINENCE DEVICES MARKET FOR URINARY CATHETERS, BY TYPE, 2022-2030 (USD MILLION)
  • TABLE 151 UK: URINARY INCONTINENCE DEVICES MARKET, BY INCONTINENCE TYPE, 2022-2030 (USD MILLION)
  • TABLE 152 UK: URINARY INCONTINENCE DEVICES MARKET, BY PATIENT TYPE, 2022-2030 (USD MILLION)
  • TABLE 153 UK: URINARY INCONTINENCE DEVICES MARKET, BY END USER, 2022-2030 (USD MILLION)
  • TABLE 154 FRANCE: URINARY INCONTINENCE DEVICES MARKET, BY PRODUCT, 2022-2030 (USD MILLION)
  • TABLE 155 FRANCE: URINARY INCONTINENCE DEVICES MARKET FOR URINARY CATHETERS, BY TYPE, 2022-2030 (USD MILLION)
  • TABLE 156 FRANCE: URINARY INCONTINENCE DEVICES MARKET, BY INCONTINENCE TYPE, 2022-2030 (USD MILLION)
  • TABLE 157 FRANCE: URINARY INCONTINENCE DEVICES MARKET, BY PATIENT TYPE, 2022-2030 (USD MILLION)
  • TABLE 158 FRANCE: URINARY INCONTINENCE DEVICES MARKET, BY END USER, 2022-2030 (USD MILLION)
  • TABLE 159 ITALY: URINARY INCONTINENCE DEVICES MARKET, BY PRODUCT, 2022-2030 (USD MILLION)
  • TABLE 160 ITALY: URINARY INCONTINENCE DEVICES MARKET FOR URINARY CATHETERS, BY TYPE, 2022-2030 (USD MILLION)
  • TABLE 161 ITALY: URINARY INCONTINENCE DEVICES MARKET, BY INCONTINENCE TYPE, 2022-2030 (USD MILLION)
  • TABLE 162 ITALY: URINARY INCONTINENCE DEVICES MARKET, BY PATIENT TYPE, 2022-2030 (USD MILLION)
  • TABLE 163 ITALY: URINARY INCONTINENCE DEVICES MARKET, BY END USER, 2022-2030 (USD MILLION)
  • TABLE 164 SPAIN: URINARY INCONTINENCE DEVICES MARKET, BY PRODUCT, 2022-2030 (USD MILLION)
  • TABLE 165 SPAIN: URINARY INCONTINENCE DEVICES MARKET FOR URINARY CATHETERS, BY TYPE, 2022-2030 (USD MILLION)
  • TABLE 166 SPAIN: URINARY INCONTINENCE DEVICES MARKET, BY INCONTINENCE TYPE, 2022-2030 (USD MILLION)
  • TABLE 167 SPAIN: URINARY INCONTINENCE DEVICES MARKET, BY PATIENT TYPE, 2022-2030 (USD MILLION)
  • TABLE 168 SPAIN: URINARY INCONTINENCE DEVICES MARKET, BY END USER, 2022-2030 (USD MILLION)
  • TABLE 169 REST OF EUROPE: URINARY INCONTINENCE DEVICES MARKET, BY PRODUCT, 2022-2030 (USD MILLION)
  • TABLE 170 REST OF EUROPE: URINARY INCONTINENCE DEVICES MARKET FOR URINARY CATHETERS, BY TYPE, 2022-2030 (USD MILLION)
  • TABLE 171 REST OF EUROPE: URINARY INCONTINENCE DEVICES MARKET, BY INCONTINENCE TYPE, 2022-2030 (USD MILLION)
  • TABLE 172 REST OF EUROPE: URINARY INCONTINENCE DEVICES MARKET, BY PATIENT TYPE, 2022-2030 (USD MILLION)
  • TABLE 173 REST OF EUROPE: URINARY INCONTINENCE DEVICES MARKET, BY END USER, 2022-2030 (USD MILLION)
  • TABLE 174 ASIA PACIFIC: MACROECONOMIC INDICATORS
  • TABLE 175 ASIA PACIFIC: URINARY INCONTINENCE DEVICES MARKET, BY PRODUCT, 2022-2030 (USD MILLION)
  • TABLE 176 ASIA PACIFIC: URINARY INCONTINENCE DEVICES MARKET FOR URINARY CATHETERS, BY TYPE, 2022-2030 (USD MILLION)
  • TABLE 177 ASIA PACIFIC: URINARY INCONTINENCE DEVICES MARKET, BY INCONTINENCE TYPE, 2022-2030 (USD MILLION)
  • TABLE 178 ASIA PACIFIC: URINARY INCONTINENCE DEVICES MARKET, BY PATIENT TYPE, 2022-2030 (USD MILLION)
  • TABLE 179 ASIA PACIFIC: URINARY INCONTINENCE DEVICES MARKET, BY END USER, 2022-2030 (USD MILLION)
  • TABLE 180 ASIA PACIFIC: URINARY INCONTINENCE DEVICES MARKET, BY COUNTRY, 2022-2030 (USD MILLION)
  • TABLE 181 CHINA: URINARY INCONTINENCE DEVICES MARKET, BY PRODUCT, 2022-2030 (USD MILLION)
  • TABLE 182 CHINA: URINARY INCONTINENCE DEVICES MARKET FOR URINARY CATHETERS, BY TYPE, 2022-2030 (USD MILLION)
  • TABLE 183 CHINA: URINARY INCONTINENCE DEVICES MARKET, BY INCONTINENCE TYPE, 2022-2030 (USD MILLION)
  • TABLE 184 CHINA: URINARY INCONTINENCE DEVICES MARKET, BY PATIENT TYPE, 2022-2030 (USD MILLION)
  • TABLE 185 CHINA: URINARY INCONTINENCE DEVICES MARKET, BY END USER, 2022-2030 (USD MILLION)
  • TABLE 186 JAPAN: URINARY INCONTINENCE DEVICES MARKET, BY PRODUCT, 2022-2030 (USD MILLION)
  • TABLE 187 JAPAN: URINARY INCONTINENCE DEVICES MARKET FOR URINARY CATHETERS, BY TYPE, 2022-2030 (USD MILLION)
  • TABLE 188 JAPAN: URINARY INCONTINENCE DEVICES MARKET, BY INCONTINENCE TYPE, 2022-2030 (USD MILLION)
  • TABLE 189 JAPAN: URINARY INCONTINENCE DEVICES MARKET, BY PATIENT TYPE, 2022-2030 (USD MILLION)
  • TABLE 190 JAPAN: URINARY INCONTINENCE DEVICES MARKET, BY END USER, 2022-2030 (USD MILLION)
  • TABLE 191 INDIA: URINARY INCONTINENCE DEVICES MARKET, BY PRODUCT, 2022-2030 (USD MILLION)
  • TABLE 192 INDIA: URINARY INCONTINENCE DEVICES MARKET FOR URINARY CATHETERS, BY TYPE, 2022-2030 (USD MILLION)
  • TABLE 193 INDIA: URINARY INCONTINENCE DEVICES MARKET, BY INCONTINENCE TYPE, 2022-2030 (USD MILLION)
  • TABLE 194 INDIA: URINARY INCONTINENCE DEVICES MARKET, BY PATIENT TYPE, 2022-2030 (USD MILLION)
  • TABLE 195 INDIA: URINARY INCONTINENCE DEVICES MARKET, BY END USER, 2022-2030 (USD MILLION)
  • TABLE 196 REST OF ASIA PACIFIC: URINARY INCONTINENCE DEVICES MARKET, BY PRODUCT, 2022-2030 (USD MILLION)
  • TABLE 197 REST OF ASIA PACIFIC: URINARY INCONTINENCE DEVICES MARKET FOR URINARY CATHETERS, BY TYPE, 2022-2030 (USD MILLION)
  • TABLE 198 REST OF ASIA PACIFIC: URINARY INCONTINENCE DEVICES MARKET, BY INCONTINENCE TYPE, 2022-2030 (USD MILLION)
  • TABLE 199 REST OF ASIA PACIFIC: URINARY INCONTINENCE DEVICES MARKET, BY PATIENT TYPE, 2022-2030 (USD MILLION)
  • TABLE 200 REST OF ASIA PACIFIC: URINARY INCONTINENCE DEVICES MARKET, BY END USER, 2022-2030 (USD MILLION)
  • TABLE 201 LATIN AMERICA: MACROECONOMIC INDICATORS
  • TABLE 202 LATIN AMERICA: URINARY INCONTINENCE DEVICES MARKET, BY PRODUCT, 2022-2030 (USD MILLION)
  • TABLE 203 LATIN AMERICA: URINARY INCONTINENCE DEVICES MARKET FOR URINARY CATHETERS, BY TYPE, 2022-2030 (USD MILLION)
  • TABLE 204 LATIN AMERICA: URINARY INCONTINENCE DEVICES MARKET, BY INCONTINENCE TYPE, 2022-2030 (USD MILLION)
  • TABLE 205 LATIN AMERICA: URINARY INCONTINENCE DEVICES MARKET, BY PATIENT TYPE, 2022-2030 (USD MILLION)
  • TABLE 206 LATIN AMERICA: URINARY INCONTINENCE DEVICES MARKET, BY END USER, 2022-2030 (USD MILLION)
  • TABLE 207 LATIN AMERICA: URINARY INCONTINENCE DEVICES MARKET, BY COUNTRY, 2022-2030 (USD MILLION)
  • TABLE 208 BRAZIL: URINARY INCONTINENCE DEVICES MARKET, BY PRODUCT, 2022-2030 (USD MILLION)
  • TABLE 209 BRAZIL: URINARY INCONTINENCE DEVICES MARKET FOR URINARY CATHETERS, BY TYPE, 2022-2030 (USD MILLION)
  • TABLE 210 BRAZIL: URINARY INCONTINENCE DEVICES MARKET, BY INCONTINENCE TYPE, 2022-2030 (USD MILLION)
  • TABLE 211 BRAZIL: URINARY INCONTINENCE DEVICES MARKET, BY PATIENT TYPE, 2022-2030 (USD MILLION)
  • TABLE 212 BRAZIL: URINARY INCONTINENCE DEVICES MARKET, BY END USER, 2022-2030 (USD MILLION)
  • TABLE 213 MEXICO: URINARY INCONTINENCE DEVICES MARKET, BY PRODUCT, 2022-2030 (USD MILLION)
  • TABLE 214 MEXICO: URINARY INCONTINENCE DEVICES MARKET FOR URINARY CATHETERS, BY TYPE, 2022-2030 (USD MILLION)
  • TABLE 215 MEXICO: URINARY INCONTINENCE DEVICES MARKET, BY INCONTINENCE TYPE, 2022-2030 (USD MILLION)
  • TABLE 216 MEXICO: URINARY INCONTINENCE DEVICES MARKET, BY PATIENT TYPE, 2022-2030 (USD MILLION)
  • TABLE 217 MEXICO: URINARY INCONTINENCE DEVICES MARKET, BY END USER, 2022-2030 (USD MILLION)
  • TABLE 218 REST OF LATIN AMERICA: URINARY INCONTINENCE DEVICES MARKET, BY PRODUCT, 2022-2030 (USD MILLION)
  • TABLE 219 REST OF LATIN AMERICA: URINARY INCONTINENCE DEVICES MARKET FOR URINARY CATHETERS, BY TYPE, 2022-2030 (USD MILLION)
  • TABLE 220 REST OF LATIN AMERICA: URINARY INCONTINENCE DEVICES MARKET, BY INCONTINENCE TYPE, 2022-2030 (USD MILLION)
  • TABLE 221 REST OF LATIN AMERICA: URINARY INCONTINENCE DEVICES MARKET, BY PATIENT TYPE, 2022-2030 (USD MILLION)
  • TABLE 222 REST OF LATIN AMERICA: URINARY INCONTINENCE DEVICES MARKET, BY END USER, 2022-2030 (USD MILLION)
  • TABLE 223 MIDDLE EAST & AFRICA: MACROECONOMIC INDICATORS
  • TABLE 224 MIDDLE EAST & AFRICA: URINARY INCONTINENCE DEVICES MARKET, BY PRODUCT, 2022-2030 (USD MILLION)
  • TABLE 225 MIDDLE EAST & AFRICA: URINARY INCONTINENCE DEVICES MARKET FOR URINARY CATHETERS, BY TYPE, 2022-2030 (USD MILLION)
  • TABLE 226 MIDDLE EAST & AFRICA: URINARY INCONTINENCE DEVICES MARKET, BY INCONTINENCE TYPE, 2022-2030 (USD MILLION)
  • TABLE 227 MIDDLE EAST & AFRICA: URINARY INCONTINENCE DEVICES MARKET, BY PATIENT TYPE, 2022-2030 (USD MILLION)
  • TABLE 228 MIDDLE EAST & AFRICA: URINARY INCONTINENCE DEVICES MARKET, BY END USER, 2022-2030 (USD MILLION)
  • TABLE 229 OVERVIEW OF STRATEGIES DEPLOYED BY KEY PLAYERS IN URINARY INCONTINENCE DEVICES MARKET
  • TABLE 230 URINARY INCONTINENCE DEVICES MARKET: DEGREE OF COMPETITION
  • TABLE 231 URINARY INCONTINENCE DEVICES MARKET: REGION FOOTPRINT
  • TABLE 232 URINARY INCONTINENCE DEVICES MARKET: PRODUCT FOOTPRINT
  • TABLE 233 URINARY INCONTINENCE DEVICES MARKET: PATIENT TYPE FOOTPRINT
  • TABLE 234 URINARY INCONTINENCE DEVICES MARKET: END-USER FOOTPRINT
  • TABLE 235 URINARY INCONTINENCE DEVICES MARKET: DETAILED LIST OF KEY STARTUP/SME PLAYERS
  • TABLE 236 URINARY INCONTINENCE DEVICES MARKET: COMPETITIVE BENCHMARKING OF KEY EMERGING PLAYERS/STARTUPS
  • TABLE 237 URINARY INCONTINENCE DEVICES MARKET: PRODUCT LAUNCHES & APPROVALS, JANUARY 2021-JANUARY 2025
  • TABLE 238 URINARY INCONTINENCE DEVICES MARKET: DEALS, JANUARY 2021-JANUARY 2025
  • TABLE 239 URINARY INCONTINENCE DEVICES MARKET: EXPANSIONS, JANUARY 2021-JANUARY 2025
  • TABLE 240 URINARY INCONTINENCE DEVICES MARKET: OTHER DEVELOPMENTS, JANUARY 2021-JANUARY 2025
  • TABLE 241 COLOPLAST CORP.: COMPANY OVERVIEW
  • TABLE 242 EXCHANGE RATES USED FOR CONVERSION OF DKK TO USD
  • TABLE 243 COLOPLAST CORP.: PRODUCTS OFFERED
  • TABLE 244 COLOPLAST CORP.: PRODUCT LAUNCHES, JANUARY 2021-JANUARY 2025
  • TABLE 245 COLOPLAST CORP.: EXPANSIONS, JANUARY 2021-JANUARY 2025
  • TABLE 246 B. BRAUN SE: COMPANY OVERVIEW
  • TABLE 247 EXCHANGE RATES USED FOR CONVERSION OF EURO TO USD
  • TABLE 248 B. BRAUN SE: PRODUCTS OFFERED
  • TABLE 249 JOHNSON & JOHNSON SERVICES, INC.: COMPANY OVERVIEW
  • TABLE 250 JOHNSON & JOHNSON SERVICES, INC.: PRODUCTS OFFERED
  • TABLE 251 CONVATEC INC.: COMPANY OVERVIEW
  • TABLE 252 CONVATEC INC.: PRODUCTS OFFERED
  • TABLE 253 CONVATEC INC.: PRODUCT LAUNCHES, JANUARY 2021-JANUARY 2025
  • TABLE 254 CONVATEC INC.: DEALS, JANUARY 2021- JANUARY 2025
  • TABLE 255 BOSTON SCIENTIFIC CORPORATION: COMPANY OVERVIEW
  • TABLE 256 BOSTON SCIENTIFIC CORPORATION: PRODUCTS OFFERED
  • TABLE 257 BOSTON SCIENTIFIC CORPORATION: DEALS, JANUARY 2021- JANUARY 2025
  • TABLE 258 MEDTRONIC: COMPANY OVERVIEW
  • TABLE 259 MEDTRONIC: PRODUCTS OFFERED
  • TABLE 260 MEDTRONIC: PRODUCT APPROVALS, JANUARY 2021-JANUARY 2025
  • TABLE 261 TELEFLEX INCORPORATED: COMPANY OVERVIEW
  • TABLE 262 TELEFLEX INCORPORATED: PRODUCTS OFFERED
  • TABLE 263 BECTON, DICKINSON AND COMPANY (BD): COMPANY OVERVIEW
  • TABLE 264 BECTON, DICKINSON AND COMPANY (BD): PRODUCTS OFFERED
  • TABLE 265 CARDINAL HEALTH: COMPANY OVERVIEW
  • TABLE 266 CARDINAL HEALTH: PRODUCTS OFFERED
  • TABLE 267 HOLLISTER INCORPORATED: COMPANY OVERVIEW
  • TABLE 268 HOLLISTER INCORPORATED: PRODUCTS OFFERED
  • TABLE 269 HOLLISTER INCORPORATED: PRODUCT LAUNCHES, JANUARY 2021-JANUARY 2025
  • TABLE 270 COOK GROUP: COMPANY OVERVIEW
  • TABLE 271 COOK GROUP: PRODUCTS OFFERED
  • TABLE 272 LABORIE: COMPANY OVERVIEW
  • TABLE 273 LABORIE: PRODUCTS OFFERED
  • TABLE 274 LABORIE: OTHER DEVELOPMENTS, JANUARY 2021-JANUARY 2025
  • TABLE 275 WELLSPECT HEALTHCARE: COMPANY OVERVIEW
  • TABLE 276 CALDERA MEDICAL: COMPANY OVERVIEW
  • TABLE 277 DYNAREX CORPORATION: COMPANY OVERVIEW
  • TABLE 278 ADVACARE PHARMA: COMPANY OVERVIEW
  • TABLE 279 MRK HEALTHCARE PVT. LTD.: COMPANY OVERVIEW
  • TABLE 280 ADVIN HEALTH CARE: COMPANY OVERVIEW
  • TABLE 281 CLINIMED LIMITED: COMPANY OVERVIEW
  • TABLE 282 STERIMED GROUP: COMPANY OVERVIEW
  • TABLE 283 KIMBERLEY-CLARK CORPORATION (KCWW): COMPANY OVERVIEW
  • TABLE 284 INCONTROL MEDICAL: COMPANY OVERVIEW
  • TABLE 285 ZEPHYR SURGICAL IMPLANTS: COMPANY OVERVIEW
  • TABLE 286 FLEXICARE (GROUP) LIMITED: COMPANY OVERVIEW
  • TABLE 287 STRYKER: COMPANY OVERVIEW

List of Figures

  • FIGURE 1 URINARY INCONTINENCE DEVICES MARKET: RESEARCH DESIGN
  • FIGURE 2 URINARY INCONTINENCE DEVICES MARKET: KEY DATA FROM SECONDARY SOURCES
  • FIGURE 3 URINARY INCONTINENCE DEVICES MARKET: KEY PRIMARY SOURCES
  • FIGURE 4 URINARY INCONTINENCE DEVICES MARKET: KEY INDUSTRY INSIGHTS
  • FIGURE 5 BREAKDOWN OF PRIMARY INTERVIEWS: SUPPLY-SIDE AND DEMAND-SIDE PARTICIPANTS
  • FIGURE 6 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
  • FIGURE 7 URINARY INCONTINENCE DEVICES MARKET: REVENUE SHARE ANALYSIS
  • FIGURE 8 URINARY INCONTINENCE DEVICES MARKET: US-BASED APPROACH
  • FIGURE 9 CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS
  • FIGURE 10 URINARY INCONTINENCE DEVICES MARKET: TOP-DOWN APPROACH
  • FIGURE 11 URINARY INCONTINENCE DEVICES MARKET: DATA TRIANGULATION
  • FIGURE 12 URINARY INCONTINENCE DEVICES MARKET, BY PRODUCT, 2024 VS. 2030 (USD MILLION)
  • FIGURE 13 URINARY INCONTINENCE DEVICES MARKET, BY INCONTINENCE TYPE, 2024 VS. 2030 (USD MILLION)
  • FIGURE 14 URINARY INCONTINENCE DEVICES MARKET, BY PATIENT TYPE, 2024 VS. 2030 (USD MILLION)
  • FIGURE 15 URINARY INCONTINENCE DEVICES MARKET, BY END USER, 2024 VS. 2030 (USD MILLION)
  • FIGURE 16 GEOGRAPHIC SNAPSHOT OF URINARY INCONTINENCE DEVICES MARKET
  • FIGURE 17 RISING PREVALENCE OF URINARY INCONTINENCE TO PROPEL MARKET
  • FIGURE 18 URINARY CATHETERS SEGMENT ACCOUNTED FOR LARGEST MARKET SHARE IN CHINA IN 2023
  • FIGURE 19 CHINA TO RECORD HIGHEST CAGR DURING FORECAST PERIOD
  • FIGURE 20 ASIA PACIFIC TO WITNESS HIGHEST GROWTH RATE DURING FORECAST PERIOD
  • FIGURE 21 EMERGING MARKETS TO REGISTER HIGHER GROWTH RATES DURING FORECAST PERIOD
  • FIGURE 22 URINARY INCONTINENCE DEVICES MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
  • FIGURE 23 URINARY INCONTINENCE DEVICES MARKET: VALUE CHAIN ANALYSIS
  • FIGURE 24 URINARY INCONTINENCE DEVICES MARKET: SUPPLY CHAIN ANALYSIS
  • FIGURE 25 URINARY INCONTINENCE DEVICES MARKET: ECOSYSTEM ANALYSIS
  • FIGURE 26 KEY PLAYERS IN URINARY INCONTINENCE DEVICES MARKET ECOSYSTEM
  • FIGURE 27 URINARY INCONTINENCE DEVICES MARKET: PORTER'S FIVE FORCES ANALYSIS
  • FIGURE 28 INFLUENCE OF KEY STAKEHOLDERS ON BUYING PROCESS
  • FIGURE 29 KEY BUYING CRITERIA FOR MAJOR END USERS
  • FIGURE 30 PATENT ANALYSIS FOR URINARY INCONTINENCE DEVICES, JANUARY 1, 2015-DECEMBER 31, 2024
  • FIGURE 31 URINARY INCONTINENCE DEVICES MARKET: TRENDS & DISRUPTIONS IMPACTING CUSTOMERS' BUSINESSES
  • FIGURE 32 URINARY INCONTINENCE DEVICES MARKET: INVESTMENT & FUNDING SCENARIO
  • FIGURE 33 EUROPE: URINARY INCONTINENCE DEVICES MARKET SNAPSHOT
  • FIGURE 34 ASIA PACIFIC: URINARY INCONTINENCE DEVICES MARKET SNAPSHOT
  • FIGURE 35 REVENUE ANALYSIS OF KEY PLAYERS IN URINARY INCONTINENCE DEVICES MARKET (2019-2023)
  • FIGURE 36 MARKET SHARE ANALYSIS OF KEY PLAYERS IN URINARY INCONTINENCE DEVICES MARKET (2023)
  • FIGURE 37 URINARY INCONTINENCE DEVICES MARKET: COMPANY EVALUATION MATRIX (KEY PLAYERS), 2023
  • FIGURE 38 URINARY INCONTINENCE DEVICES MARKET: COMPANY FOOTPRINT
  • FIGURE 39 URINARY INCONTINENCE DEVICES MARKET: COMPANY EVALUATION MATRIX (STARTUPS/SMES), 2023
  • FIGURE 40 EV/EBITDA OF KEY VENDORS, 2023-2024
  • FIGURE 41 YEAR-TO-DATE (YTD) PRICE TOTAL RETURN AND 5-YEAR STOCK BETA OF KEY VENDORS
  • FIGURE 42 URINARY INCONTINENCE DEVICES MARKET: BRAND/PRODUCT COMPARATIVE ANALYSIS
  • FIGURE 43 COLOPLAST CORP.: COMPANY SNAPSHOT
  • FIGURE 44 B. BRAUN SE: COMPANY SNAPSHOT
  • FIGURE 45 JOHNSON & JOHNSON SERVICES, INC.: COMPANY SNAPSHOT
  • FIGURE 46 CONVATEC INC.: COMPANY SNAPSHOT
  • FIGURE 47 BOSTON SCIENTIFIC CORPORATION: COMPANY SNAPSHOT
  • FIGURE 48 MEDTRONIC: COMPANY SNAPSHOT
  • FIGURE 49 TELEFLEX INCORPORATED: COMPANY SNAPSHOT
  • FIGURE 50 BECTON, DICKINSON AND COMPANY (BD): COMPANY SNAPSHOT
  • FIGURE 51 CARDINAL HEALTH: COMPANY SNAPSHOT